ResearchImmunologyOncology Open Access | 10.1172/JCI204359 J Clin Invest. https://doi.org/10.1172/JCI204359. Copyright © 2026, Liu et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. View PDF Abstract NK cell-based therapies for solid tumors are limited by poor persistence and progressive functional impairment.
Ryan Brown
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ryan
Contact Ryan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack